MedPath

Investigation of serum level of antituberculous and genetic polymorphism in NAT2 gene in patinet with pulmonary tuberculosis

Not Applicable
Recruiting
Conditions
pulmonary tuberculosis
Registration Number
JPRN-UMIN000006664
Lead Sponsor
Fukushima Medeical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patinet with drug resistant tuberculosis. 2) Patinet with Human Immunodeficiency virus

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration until acid-fast bacillus sputum examination converts to negative among objective patients.
Secondary Outcome Measures
NameTimeMethod
The frequency and severity of adverse effects due to anti-tuberculous drugs among objective patinets
© Copyright 2025. All Rights Reserved by MedPath